Immune‐regulatory mechanisms in systemic autoimmune and rheumatic diseases

Y Takakubo, YT Konttinen - Journal of Immunology Research, 2012 - Wiley Online Library
Systemic autoimmune and rheumatic diseases (SAIRDs) are thought to develop due to the
failure of autoimmune regulation and tolerance. Current therapies, such as biologics, have …

Medications, therapeutic modalities, and regimens used in the management of rheumatic diseases

HM Moutsopoulos, E Zampeli - Immunology and Rheumatology in …, 2021 - Springer
Therapy of systemic autoimmune rheumatic diseases can still be a challenge for clinicians
despite enormous progress made in the last decades on the understanding of the …

Low-dose IL-2 therapy in autoimmune and rheumatic diseases

H Graßhoff, S Comdühr, LR Monne, A Müller… - Frontiers in …, 2021 - frontiersin.org
Regulatory T cells (Treg) are crucial for the maintenance of peripheral tolerance and for the
control of ongoing inflammation and autoimmunity. The cytokine interleukin-2 (IL-2) is …

Current strategies for the treatment of autoimmune diseases

E Rosato, S Pisarri, F Salsano - Journal of biological …, 2010 - pubmed.ncbi.nlm.nih.gov
Autoimmune disease therapy may be considered a puzzle under construction. Current
treatments for autoimmune diseases include physical therapy, non-steroidal anti …

Novel therapeutic strategies for autoimmune and inflammatory rheumatic diseases

R Felten, P Mertz, E Sebbag, M Scherlinger… - Drug Discovery …, 2023 - Elsevier
Drugs of unknown mechanisms of action are no longer being developed because we have
largely capitalized on our improved understanding of the immunopathogenesis of immune …

[HTML][HTML] Understanding Autoimmunity: Mechanisms, Predisposing Factors, and Cytokine Therapies

F Yasmeen, RH Pirzada, B Ahmad, B Choi… - International Journal of …, 2024 - mdpi.com
Autoimmunity refers to an organism's immune response against its own healthy cells,
tissues, or components, potentially leading to irreversible damage to vital organs. Central …

Cell therapy for autoimmune diseases: does it have a future?

A Radbruch, A Thiel - Annals of the rheumatic diseases, 2004 - ard.bmj.com
Almost all current therapeutic concepts in autoimmune diseases are based on the systemic
suppression of immune functions and are not curative. The recent introduction of biologicals …

Therapeutic potential of regulatory T cells in autoimmune disorders

J Fessler, A Felber, C Duftner, C Dejaco - BioDrugs, 2013 - Springer
Regulatory T cells (Tregs) play a dominant role in the regulation of immune responses.
Quantitative and/or qualitative abnormalities of Tregs were observed in patients with …

The Yin and Yang of regulatory T cell and therapy progress in autoimmune disease

Y Qiao, Y Pan, W Ling, F Tian, Y Chen, X Zhang… - Autoimmunity …, 2017 - Elsevier
Autoimmune diseases (ADs) are primarily mediated by the failure of immunological self-
tolerance. Regulatory T cells (Tregs) play a critical role in the maintenance of induced …

Interleukin-2 and regulatory T cells in rheumatic diseases

AGA Kolios, GC Tsokos, D Klatzmann - Nature Reviews Rheumatology, 2021 - nature.com
Failure of regulatory T (Treg) cells to properly control immune responses leads invariably to
autoimmunity and organ damage. Decreased numbers or impaired function of Treg cells …